Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Aldesleukin (inhalation use)

EU orphan designation number: EU/3/03/146
Active ingredient: Aldesleukin (inhalation use)
Indication: Treatment of renal cell carcinoma
Sponsor: Chiron Corporation Ltd
Symphony House, 7 Cowley Business Park, High Street, Cowley, Uxbridge, UB8 2AD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/07/2003 Orphan designation EMEA/OD/006/03 (2003)2215 of 30/06/2003
30/11/2005 Transfer of orphan designation EMEA/OD/006/03/T/01 (2005)4723 of 28/11/2005
04/10/2006 Removal of orphan designation from Community Register